Help us determine whether surface electromyography is a valid tool for ALS diagnosis and tracking of disease progression
Recruiting patients and controls
Study Name
Intermuscular Coherence as a Biomarker for ALS (ALS-IMC)
PI
Nathan Carberry, MD
Study Type
Observational, Prospective, Biomarker
Eligible Population
- Individuals aged 18+ with a suspected diagnosis of amyotrophic lateral sclerosis (ALS)
- Healthy individuals between the ages of 20 to 90
Study Purpose/Goals
To determine whether surface electromyography is a valid tool for ALS diagnosis and tracking of disease progression
Procedures/Participation
- 1-hour study visit in Miami (# of visits may vary) including:
-
- Medical history review
- Collection of demographic information
- ALSFRS-R
- Surface EMG
Contact
Join our family - together, we can change the course of this disease.
Join our family
Together, we can change the course of this disease.
ALS Treatment
About Us
